BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  UK Plays Mix-n-Match with COVID-19 Vaccines

  The University of Oxford in the U.K., with the National Immunisation Schedule Evaluation Consortium, is planning a trial to evaluate the use of first and second doses of different COVID-19 vaccines.

  February 4, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Merck’s Longtime CEO Ken Frazier Steps Down After Nearly 30 Years

  Merck Chief Executive Officer Kenneth C. Frazier is stepping down from his role atop the helm of the pharma giant on June 30 after nearly 30 years with the company.

  February 4, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Bio NC

  Bryn’s Fear-Free Emergency Epinephrine Solution for Anaphylaxis

  Anaphylaxis is a serious and potentially fatal allergy to bee venom, food, and medication, and only 50-60% of the affected population is adequately prepared for an attack. Even less are prepared in severe cases where a second dose is required.

  February 4, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Career Advice

  Thought Starters for Brainstorming Your 2021 Goals

  To help you kick off your yearly goal planning, we put together a series of prompts to get your brain mulling over achievable goals to set for 2021.

  February 4, 2021

   · 

  2 min read

   · 

  Laura Brothers
• 

  Deals

  Life Sciences Companies Ringing the Nasdaq Bell this Week

  Sana Biotechnology led the way with a very large initial public offering that could bring the company’s market value to $4.6 billion or more. But it’s not the only IPO this week. Here’s a look.

  February 4, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Life Sciences Dollars Flow Despite Global Recession

  The economy is depressed, but investors are impressed with these life science companies.

  February 4, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Roche Washes Hands of Mid and Late-Stage Trial Failures

  Roche is closing out its fourth-quarter with some house cleaning. The Swiss pharma giant announced in its earnings report that it was terminating studies of several mid- and late-stage assets, including two late-stage breast cancer programs.

  February 4, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  FDA Recalls Catheter, Cardiac Devices and Meds Over Safety Issues

  From packaging errors and contaminants to serious adverse effects, there are many reasons why products in the life sciences industry get recalled. Here’s a look at some of the latest drug and medical device recalls.

  February 4, 2021

   · 

  3 min read

   · 

  Mark Zipkin
• 

  Pharm Country

  Investigation Finds Merck’s Anti-Baldness Drug Finasteride Long Linked to Suicide Reports

  A new report shows Merck’s anti-baldness drug Propecia (finasteride) has been linked to more than 700 incidences of suicide and suicidal thoughts, side effects that both Merck and U.S. regulators allegedly knew about since 2011.

  February 4, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  BioSpace Movers & Shakers: MoMa Therapeutics, Cerevance, Glympse Bio and More

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  February 4, 2021

   · 

  8 min read

   · 

  Alex Keown